On Friday, Chemours received an upgrade to its Relative Strength (RS) Rating, from 61 to 73.
When To Sell Stocks To Lock In Profits And Minimize Losses
This unique rating measures technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the last 52 weeks matched up against all other stocks.
Over 100 years of market history shows that the stocks that go on to make the biggest gains often have an RS Rating of over 80 in the early stages of their moves. See if Chemours can continue to show renewed price strength and hit that benchmark.
While Chemours is not near a proper buying range right now, see if it goes on to form and break out of a proper base.
In terms of top and bottom line numbers, Chemours has posted rising EPS growth over the last two quarters. Sales gains have also increased during the same period. The company is expected to report its next quarterly numbers on or around Oct. 22.
Chemours earns the No. 11 rank among its peers in the Chemicals-Specialty industry group. Solaris Energy Infr, Perimeter Solutions and NewMarket are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
